FDA Approves BLINCYTOTM (blinatumomab)
- FLASCO
- March 10, 2015
- Drugs
FDA Approves BLINCYTOTM (blinatumomab)
the U.S. Food and Drug Administration approved BLINCYTOTM (blinatumomab) for injection, for intravenous use.
| Trade Name | NDC* | Pack Size | WAC |
| BLINCYTOTM | 55513-0160-01 | 35 mcg lyophilized powder, single use vial
IVSS (IV Solution Stabilizer) 10 mL single use vial |
$ 3178.57 |
*Note that the product’s NDC code has been “zero-filled” to ensure creation of an 11-digit code that meets CMS standards. The zero-fill location is indicated in bold.2
Please click here for the Full Prescribing Information, including Boxed WARNINGS and Medication Guide.
If you require any additional information or have specific questions regarding this correspondence, please contact the Onyx Pharmaceuticals 360™ Program at 855-ONYX-360 (855-669-9360).
